Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
14.57
+0.01 (0.07%)
At close: Feb 27, 2026, 4:00 PM EST
14.55
-0.02 (-0.14%)
After-hours: Feb 27, 2026, 4:10 PM EST
Carlsmed Revenue
In the year 2025, Carlsmed had annual revenue of $50.51M with 85.94% growth. Carlsmed had revenue of $15.17M in the quarter ending December 31, 2025, with 61.19% growth.
Revenue (ttm)
$50.51M
Revenue Growth
+85.94%
P/S Ratio
7.67
Revenue / Employee
$505,110
Employees
100
Market Cap
387.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.51M | 23.35M | 85.94% |
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCARL News
- 2 days ago - Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 days ago - Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - GlobeNewsWire
- 10 days ago - Carlsmed Announces first corra™ personalized Cervical Plating Procedure - GlobeNewsWire
- 17 days ago - Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 18 days ago - Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - GlobeNewsWire
- 6 weeks ago - Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - GlobeNewsWire
- 7 weeks ago - Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal - GlobeNewsWire